According to Zhitong Finance App, Hengrui Pharmaceutical (01276.HK) announced that the company spent 11.3723 million yuan to repurchase 250,000 A shares on September 23, 2026, at a repurchase price of 45.42-45.54 yuan per share.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.